Combining anti-ERBB3 antibodies specific for domain I and domain III enhances the anti-tumor activity over the individual monoclonal antibodies
about
ERBB3: A potential serum biomarker for early detection and therapeutic target for devil facial tumour 1 (DFT1)Oligoclonal antibodies to target the ErbB family.Immunotherapy of cancer: from monoclonal to oligoclonal cocktails of anti-cancer antibodies: IUPHAR Review 18.Emerging anti-cancer antibodies and combination therapies targeting HER3/ERBB3.Combination of antibodies directed against different ErbB3 surface epitopes prevents the establishment of resistance to BRAF/MEK inhibitors in melanoma.Characterizing the Hot Spots Involved in RON-MSPβ Complex Formation Using In Silico Alanine Scanning Mutagenesis and Molecular Dynamics Simulation.
P2860
Combining anti-ERBB3 antibodies specific for domain I and domain III enhances the anti-tumor activity over the individual monoclonal antibodies
description
2014 nî lūn-bûn
@nan
2014 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Combining anti-ERBB3 antibodie ...... dividual monoclonal antibodies
@ast
Combining anti-ERBB3 antibodie ...... dividual monoclonal antibodies
@en
type
label
Combining anti-ERBB3 antibodie ...... dividual monoclonal antibodies
@ast
Combining anti-ERBB3 antibodie ...... dividual monoclonal antibodies
@en
prefLabel
Combining anti-ERBB3 antibodie ...... dividual monoclonal antibodies
@ast
Combining anti-ERBB3 antibodie ...... dividual monoclonal antibodies
@en
P2093
P2860
P1433
P1476
Combining anti-ERBB3 antibodie ...... dividual monoclonal antibodies
@en
P2093
Irina Shchaveleva
James D Marks
Jimson W D'Souza
Lisa E Goldsmith
Matthew K Robinson
Samuel Litwin
Smitha Reddy
P2860
P304
P356
10.1371/JOURNAL.PONE.0112376
P407
P577
2014-11-11T00:00:00Z